|
1
|
Erkal HS, Serin M and Cakmak A:
Nasopharyngeal carcinomas: analysis of patient, tumor and treatment
characteristics determining outcome. Radiother Oncol. 61:247–256.
2001. View Article : Google Scholar
|
|
2
|
Roychowdhury DF, Tseng A Jr, Fu KK,
Weinburg V and Weidner N: New prognostic factors in nasopharyngeal
carcinoma. Tumor angiogenesis and C-erbB2 expression. Cancer.
77:1419–1426. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu MT, Hsieh CY, Chang TH, Lin JP, Huang
CC and Wang AY: Prognostic factors affecting the outcome of
nasopharyngeal carcinoma. Jpn J Clin Oncol. 33:501–508. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Geara FB, Glisson BS, Sanguineti G, et al:
Induction chemotherapy followed by radiotherapy versus radiotherapy
alone in patients with advanced nasopharyngeal carcinoma: results
of a matched cohort study. Cancer. 79:1279–1286. 1997. View Article : Google Scholar
|
|
5
|
Sanguineti G, Geara FB, Garden AS, et al:
Carcinoma of the nasopharynx treated by radiotherapy alone:
determinants of local and regional control. Int J Radiat Oncol Biol
Phys. 37:985–996. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yeh SA, Tang Y, Lui CC, Huang YJ and Huang
EY: Treatment outcomes and late complications of 849 patients with
nasopharyngeal carcinoma treated with radiotherapy alone. Int J
Radiat Oncol Biol Phys. 62:672–679. 2005. View Article : Google Scholar
|
|
7
|
Wei WH, Cai XY, Xu T, et al: Concurrent
weekly docetaxel chemotherapy in combination with radiotherapy for
stage III and IVA-B nasopharyngeal carcinoma. Asian Pac J Cancer
Prev. 13:785–789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nijkamp MM, Span PN, Hoogsteen IJ, van der
Kogel AJ, Kaanders JH and Bussink J: Expression of E-cadherin and
vimentin correlates with metastasis formation in head and neck
squamous cell carcinoma patients. Radiother Oncol. 99:344–348.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kang Y and Massagué J:
Epithelial-mesenchymal transitions: twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou YC, Liu JY, Li J, et al: Ionizing
radiation promotes migration and invasion of cancer cells through
transforming growth factor-beta-mediated epithelial-mesenchymal
transition. Int J Radiat Oncol Biol Phys. 81:1530–1537. 2011.
View Article : Google Scholar
|
|
12
|
Theys J, Jutten B, Habets R, et al:
E-Cadherin loss associated with EMT promotes radioresistance in
human tumor cells. Radiother Oncol. 99:392–397. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Y, Chen LH, Yuan YW, Li QS, Sun AM and
Guan J: Activation of AKT is associated with metastasis of
nasopharyngeal carcinoma. Tumour Biol. 33:241–245. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Castaneda CA, Cortes-Funes H, Gomez HL and
Ciruelos EM: The phosphatidyl inositol 3-kinase/AKT signaling
pathway in breast cancer. Cancer Metastasis Rev. 29:751–759. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bussink J, van der Kogel AJ and Kaanders
JH: Activation of the PI3-K/AKT pathway and implications for
radioresistance mechanisms in head and neck cancer. Lancet Oncol.
9:288–296. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rhodes N, Heerding DA, Duckett DR, et al:
Characterization of an Akt kinase inhibitor with potent
pharmacodynamic and antitumor activity. Cancer Res. 68:2366–2374.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Altomare DA, Zhang L, Deng J, et al:
GSK690693 delays tumor onset and progression in genetically defined
mouse models expressing activated Akt. Clin Cancer Res. 16:486–496.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Heerding DA, Rhodes N, Leber JD, Clark TJ,
et al: Identification of
4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn2-ol
(GSK690693), a novel inhibitor of AKT kinase. J Med Chem.
51:5663–5679. 2008.PubMed/NCBI
|
|
19
|
Andarawewa KL, Erickson AC, Chou WS, et
al: Ionizing radiation predisposes nonmalignant human mammary
epithelial cells to undergo transforming growth factor beta induced
epithelial to mesenchymal transition. Cancer Res. 67:8662–8670.
2007. View Article : Google Scholar
|
|
20
|
Li T, Zeng ZC, Wang L, et al: Radiation
enhances long-term metastasis potential of residual hepatocellular
carcinoma in nude mice through TMPRSS4-induced
epithelial-mesenchymal transition. Cancer Gene Ther. 18:617–626.
2011. View Article : Google Scholar
|
|
21
|
Santisteban M, Reiman JM, Asiedu MK, et
al: Immune-induced epithelial to mesenchymal transition in vivo
generates breast cancer stem cells. Cancer Res. 69:2887–2895. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fernandez-L A, Squatrito M, Northcott P,
et al: Oncogenic YAP promotes radioresistance and genomic
instability in medulloblastoma through IGF2-mediated Akt
activation. Oncogene. 31:1923–1937. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Carol H, Morton CL, Gorlick R, et al:
Initial testing (stage 1) of the Akt inhibitor GSK690693 by the
pediatric preclinical testing program. Pediatr Blood Cancer.
55:1329–1337. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Guo LP, Chen LZ, Zeng YX and Lu
SH: Identification of cancer stem cell-like side population cells
in human nasopharyngeal carcinoma cell line. Cancer Res.
67:3716–3724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
von Essen CF: Radiation enhancement of
metastasis: a review. Clin Exp Metastasis. 9:77–104. 1991.
|
|
26
|
Jeong JW, Jin CY, Park C, et al:
Inhibition of migration and invasion of LNCaP human prostate
carcinoma cells by cordycepin through inactivation of Akt. Int J
Oncol. 40:1697–1704. 2012.PubMed/NCBI
|
|
27
|
Setsu N, Yamamoto H, Kohashi K, et al: The
Akt/mammalian target of rapamycin pathway is activated and
associated with adverse prognosis in soft tissue leiomyosarcomas.
Cancer. 118:1637–1648. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Radisky DC: Epithelial-mesenchymal
transition. J Cell Sci. 118:4325–4326. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kurrey NK, Jalgaonkar SP, Joglekar AV, et
al: Snail and slug mediate radioresistance and chemoresistance by
antagonizing p53-mediated apoptosis and acquiring a stem-like
phenotype in ovarian cancer cells. Stem Cells. 27:2059–2068. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tanno S, Yanagawa N, Habiro A, et al:
Serine/threonine kinase AKT is frequently activated in human bile
duct cancer and is associated with increased radioresistance.
Cancer Res. 64:3486–3490. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li HF, Kim JS and Waldman T:
Radiation-induced Akt activation modulates radioresistance in human
glioblastoma cells. Radiat Oncol. 4:432009. View Article : Google Scholar : PubMed/NCBI
|
